生物标志物 生物标志物
Akihito Korenaga1, Rie Yamamoto2, Mayu Yoneyama1
1Shimadzu Corporation, Kyoto, Japan.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 24, 2025
概括
这项研究验证了使用免疫沉质谱法对阿尔茨海默病生物标志物的新等离子体测定方法. 改进的方法为大规模查提供了可靠和可重现的粉样β的测量.
科学领域:
- 生物化学 生物化学
- 神经科学是一个神经科学.
- 分析化学 分析化学
背景情况:
- 血生物标志物为阿尔茨海默病 (AD) 查提供了一种非侵入性方法.
- 以前的研究表明,血氨基酸β (Aβ) (Aβ1-40,Aβ1-42,APP669-711) 和大脑氨基酸积累之间存在相关性.
- 这项研究重点是对改进的血Aβ测定方法的分析验证.
研究的目的:
- 通过使用免疫沉矩阵辅助激光脱/离子化飞行时间质谱法 (IP-MALDI-MS) 分析验证血粉样蛋白-β测定.
- 评估用于测量血Aβ的MALDI-TOF质谱仪的性能.
- 评估试验的可重现性,真实性,动态范围,峰值回收和稀释线性.
主要方法:
- 使用抗粉胺β抗体涂层磁珠进行免疫沉.
- 使用基板MALDI-TOF质谱仪测量免疫沉样本.
- 使用稳定同位素标记的Aβ1-38作为内部标准,对强度的规范化.
- 评估生物标志物比率 (Aβ1-40/Aβ1-42和APP669-711/Aβ1-42) 的可复制性和准确性.
主要成果:
- 测试内和测试间的高可重复性,变化系数 (CV) < 5%.
- 在Aβ1-40,Aβ1-42和APP669-711的指定度范围内,准确的准确度 (100±20%) 是1.
- 极好的尖峰回收 (87-113%) 和稀释线性 (88-111%).
结论:
- 带有长板仪器的IP-MALDI-MS系统显示出足够的稳定性和可靠性,用于血Aβ的测量.
- 与以前的方法相比,经过验证的试验显示了更好的可复制性和准确性.
- 这种试验适用于使用血生物标志物的大规模阿尔茨海默病查.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516